Policy Watch: 20 Regulatory Updates — April 25, 2026
Policy WatchApril 25, 2026. 20 regulatory items above the clinical relevance threshold of 40. Sources include Federal Register, regulations.gov, and regulatory RSS feeds. Listed in descending order of relevance score. Score 70Federal RegisterSchedules of…
Schedules of Controlled Substances: Placement of 3-Methoxyphencyclidine (1-(1-(3-Methoxyphenyl)cyclohexyl)piperidine) in Schedule I
✦ New CED Clinical Relevance #70 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Policy Watch | Federal Register PolicySafetyResearch Clinical Summary The U.S. Drug Enforcement…
CED Regulatory Digest, Since Last Digest, 2 items
Digest covering 2 recent regulatory items.
Policy Watch: 10 Regulatory Updates — March 19, 2026
Policy WatchMarch 19, 2026. 10 regulatory items above the clinical relevance threshold of 40. Sources include Federal Register, regulations.gov, and regulatory RSS feeds. Listed in descending order of relevance score. Score 70Regulations.govSchedules of…
Policy Watch: 26 Regulatory Updates — March 08, 2026
Policy WatchMarch 08, 2026. 26 regulatory items above the clinical relevance threshold of 40. Sources include Federal Register, regulations.gov, and regulatory RSS feeds. Listed in descending order of relevance score. Score 70Regulations.gov Schedules of…
